WB518
WB518 is a potent STAT3 inhibitor. WB518 effectively inhibits STAT3 activation and Keratin 17 expression. WB518 effectively alleviates imiquimod (HY-B0180) and TPA (HY-18739) -induced animal psoriasis by inhibiting STAT3 phosphorylation and Keratin 17[1].
Product Specifications
UNSPSC
12352005
Target
STAT
Type
Reference compound
Related Pathways
JAK/STAT Signaling; Stem Cell/Wnt
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/wb518.html
Concentration
10mM
Purity
96.48
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
COC(C1CN(CC2=C1C(C#N)=C(S2)NC(C3=CN(N=C3)C)=O)C(C4=CC=C(O4)Br)=O)=O
Molecular Formula
C20H16BrN5O5S
Molecular Weight
518.34
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-163176/WB518-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-163176/WB518-SDS-MedChemExpress.pdf
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
STAT3
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Recombinant Archaeoglobus fulgidus F420-0:gamma-glutamyl ligase (cofE)
Recombinant Archaeoglobus fulgidus F420-0:gamma-glutamyl ligase (cofE)
Recombinant Archaeoglobus fulgidus F420-0:gamma-glutamyl ligase (cofE)